Cause of Death in Older Men After the Diagnosis of Prostate Cancer
dc.contributor.author | Ketchandji, Melanie | en_US |
dc.contributor.author | Kuo, Yong-Fang | en_US |
dc.contributor.author | Shahinian, Vahakn B. | en_US |
dc.contributor.author | Goodwin, James S. | en_US |
dc.date.accessioned | 2010-04-01T15:36:41Z | |
dc.date.available | 2010-04-01T15:36:41Z | |
dc.date.issued | 2009-01 | en_US |
dc.identifier.citation | Ketchandji, Melanie; Kuo, Yong-Fang; Shahinian, Vahakn B.; Goodwin, James S. (2009). "Cause of Death in Older Men After the Diagnosis of Prostate Cancer." Journal of the American Geriatrics Society 57(1): 24-30. <http://hdl.handle.net/2027.42/66098> | en_US |
dc.identifier.issn | 0002-8614 | en_US |
dc.identifier.issn | 1532-5415 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/66098 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19054189&dopt=citation | en_US |
dc.description.abstract | To compare survival and cause of death in men aged 65 and older diagnosed with prostate cancer and with survival and cause of death in a noncancer control population. DESIGN : Retrospective cohort from a population-based tumor registry linked to Medicare claims data. SETTING : Eleven regions of the Surveillance, Epidemiology and End Results (SEER) Tumor Registry. PARTICIPANTS : Men aged 65 to 84 (N=208,601) diagnosed with prostate cancer from 1988 through 2002 formed the basis for different analytical cohorts. MEASUREMENTS : Survival as a function of stage and tumor grade (low, Gleason grade<7; moderate, grade=7; and high, grade=8–10) was compared with survival in men without any cancer using Cox proportional hazards regression. Cause of death according to stage and tumor grade were compared using chi-square statistics. RESULTS : Men with early-stage prostate cancer and with low- to moderate-grade tumors (59.1% of the entire sample) experienced a survival not substantially worse than men without prostate cancer. In those men, cardiovascular disease and other cancers were the leading causes of death. CONCLUSION : The excellent survival of older men with early-stage, low- to moderate-grade prostate cancer, along with the patterns of causes of death, implies that this population would be well served by an ongoing focus on screening and prevention of cardiovascular disease and other cancers. | en_US |
dc.format.extent | 149049 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.rights | Journal compilation 2009 The American Geriatrics Society/Wiley Periodicals, Inc. | en_US |
dc.subject.other | Prostate Cancer | en_US |
dc.subject.other | Mortality | en_US |
dc.subject.other | Survival and Comorbidities | en_US |
dc.title | Cause of Death in Older Men After the Diagnosis of Prostate Cancer | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Geriatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan. | en_US |
dc.contributor.affiliationother | University of Texas Medical Branch, Galveston, Texas ; | en_US |
dc.contributor.affiliationother | Sealy Center on Aging ; and | en_US |
dc.identifier.pmid | 19054189 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/66098/1/j.1532-5415.2008.02091.x.pdf | |
dc.identifier.doi | 10.1111/j.1532-5415.2008.02091.x | en_US |
dc.identifier.source | Journal of the American Geriatrics Society | en_US |
dc.identifier.citedreference | Carver JR, Shapiro CL, Ng A et al. Review on the ongoing care of adult cancer survivors : Cardiac and pulmonary late effects. J Clin Oncol 2007 ; 25 : 3991 – 4008. | en_US |
dc.identifier.citedreference | Fleming ST, Pearce KA, McDavid K et al. The development and validation of a comorbidity index for prostate cancer among black men. J Clin Epidemiol 2003 ; 56 : 1064 – 1075. | en_US |
dc.identifier.citedreference | Babb P, Quinn M. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. BJU Int 2002 ; 90 : 174 – 184. | en_US |
dc.identifier.citedreference | Potosky AL, Merill RM, Riley GF et al. Prostate cancer treatment and ten-year survival among group/Staff HMO and fee-for-service Medicare patients. Health Serv Res 1999 ; 34 : 1683 – 1691. | en_US |
dc.identifier.citedreference | Robinson D, Aus G, Bak J et al. Long-term follow-up of conservatively managed incidental carcinoma of the prostate : A multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007 ; 41 : 103 – 109. | en_US |
dc.identifier.citedreference | Wong YN, Mitra N, Hudes G et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006 ; 296 : 2683 – 2693. | en_US |
dc.identifier.citedreference | Potosky AL, Riley GF, Lubitz JD et al. Potential for cancer health services research using a linked medicare-tumor registry database. Med Care 1993 ; 31 : 732. | en_US |
dc.identifier.citedreference | Sox HC, Mulrow C. An editorial update : Should benefits of radical prostatectomy affect the decision to screen for early prostate cancer? Ann Intern Med 2005 ; 143 : 232 – 233. | en_US |
dc.identifier.citedreference | Klabunde CN, Potosky AL, Legler JM et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000 ; 53 : 1258 – 1267. | en_US |
dc.identifier.citedreference | Satariano WA, Ragland KE, Van Den Eden SK. Cause of death in men diagnosed with prostate cancinoma. Cancer 1998 ; 83 : 1179 – 1184. | en_US |
dc.identifier.citedreference | 11. Deaths : Leading causes for 2004. Natl Vital Stat Rep 2007 ; 56 : 1 – 95. | en_US |
dc.identifier.citedreference | Newschaffer CJ, Otani K, McDonald MK et al. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst 2000 ; 92 : 613 – 621. | en_US |
dc.identifier.citedreference | Lu-Yao G, Stukel TA, Yao SL. Changing patterns in competing causes of death in men with prostate cancer : A population based study. J Urol 2004 ; 171 : 2285 – 2290. | en_US |
dc.identifier.citedreference | Fitzpatrick JM. Management of localized prostate cancer in senior adults : The crucial role of comorbidity. BJU Int 2008 ; 101 ( Suppl 2 ) : 16 – 22. | en_US |
dc.identifier.citedreference | Tewari A, Johnson CC, Divine G et al. Long-term survival probability in men with clinically localized prostate cancer : A case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004 ; 171 : 1513 – 1519. | en_US |
dc.identifier.citedreference | Shahinian VB, Kuo YF, Freeman JL et al. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer 2005 ; 103 : 1615 – 1624. | en_US |
dc.identifier.citedreference | D'Amico AV, Denham JW, Crook J et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 2007 ; 25 : 2420 – 2425. | en_US |
dc.identifier.citedreference | Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006 ; 24 : 4448 – 4456. | en_US |
dc.identifier.citedreference | Haidar A, Yassin A, Saad F et al. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male 2007 ; 10 : 189 – 196. | en_US |
dc.identifier.citedreference | D'Amico AV, Chen MH, Renshaw AA et al. Androgen suppression and radiation vs radiation alone for prostate cancer : A randomized trial. JAMA 2008 ; 299 : 289 – 295. | en_US |
dc.identifier.citedreference | Earle C, Neville B. Under use of necessary care among cancer survivors. Cancer 2004 ; 101 : 1712 – 1719. | en_US |
dc.identifier.citedreference | Earle CC, Burstein HJ, Winer EP et al. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 2003 ; 21 : 1447 – 1451. | en_US |
dc.identifier.citedreference | Welch HG, Albertsen PC, Nease RF et al. Estimating treatment benefits for the elderly : The effect of competing risks. Ann Intern Med 1996 ; 124 : 577 – 584. | en_US |
dc.identifier.citedreference | Jemal A, Clegg LX, Ward E et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004 ; 101 : 3 – 27. | en_US |
dc.identifier.citedreference | Penson D, Albertsen PC, Nelson PS et al. Determining cause of death in prostate cancer : Are death certificates valid? J Nat Cancer Inst 2001 ; 93 : 1822 – 1823. | en_US |
dc.identifier.citedreference | Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005 ; 293 : 2095 – 2101. | en_US |
dc.identifier.citedreference | Girodano SH, Kuo YF, Duan Z et al. Limits of observational data in determining outcomes from cancer therapy. Cancer 2008 ; 112 : 2456 – 2466. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.